AbbVie Revenue Per Share from 2010 to 2025

ABBV Stock  USD 171.56  2.14  1.23%   
AbbVie Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 14.90 in 2025. Revenue Per Share is the amount of revenue generated by AbbVie Inc per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
27.65
Current Value
14.9
Quarterly Volatility
8.25238062
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.5 B, Interest Expense of 2.7 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of AbbVie Inc over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. AbbVie's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 31.39710 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

AbbVie Revenue Per Share Regression Statistics

Arithmetic Mean19.51
Geometric Mean17.90
Coefficient Of Variation42.30
Mean Deviation7.19
Median17.68
Standard Deviation8.25
Sample Variance68.10
Range23.9844
R-Value0.79
Mean Square Error27.12
R-Squared0.63
Significance0.0003
Slope1.37
Total Sum of Squares1,022

AbbVie Revenue Per Share History

2025 14.9
2024 27.65
2023 30.72
2022 32.78
2021 31.75
2020 27.48
2019 22.46

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 27.65  14.90 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.